Local News Headlines: April 22, 2022
Catalent to invest $350 Million in integrated biologics drug substance and drug product manufacturing at Bloomington facilityCatalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, announced a multi-year $350 million investment at its facility in Bloomington, Indiana, to …